Market Overview:
The global animal autoimmune diseases testing market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of autoimmune diseases in animals, rising demand for companion animals, and growing awareness about animal health and wellness. The anti-nuclear antibody testing segment is expected to account for the largest share of the global animal autoimmune diseases testing market in 2018. This segment is driven by the increasing prevalence of lupus erythematosus, an autoimmune disease that affects dogs and cats. The coombs testing segment is projected to grow at the highest CAGR during the forecast period owing to its growing use in veterinary laboratories for detecting immune-mediated hemolytic anemia (IMHA) in dogs and cats. In terms of application, companion animals are expected to account for a larger share of the global animal autoimmune diseases testing market than live stock animals during the forecast period. Companion animals are increasingly being used as pets owing to their friendly nature and easy maintenance requirements; this has led to an increase in demand for diagnostic tests for detecting various types of autoimmunity disorders among these animals.
Product Definition:
The Animal Autoimmune Diseases Testing is a diagnostic tool that is used to identify autoimmune diseases in animals. The importance of this testing is that it can help to determine the cause of certain diseases and help to develop appropriate treatment plans.
Anti-Nuclear Antibody Testing:
Anti-nucleolar antibody (ANA) testing is a laboratory test used to detect the presence of an antibody in the blood that reacts with nuclear antigen in cells. ANA tests are commonly performed on patients with cancer, particularly those who have recently received treatment for cancer. The most common types of cancers associated with ANA include lymphoma and leukemia.
Coombs Testing:
Coombs Test is also known as Coomb’s test or serum progesterone test. It is used to detect the presence of anti-social antibodies in the blood. Anti-social antibodies are produced in animals during an attack of “lupus”, a disease that humans can get too. This test has been around for quite some time and was named after its discoverer Dr. Charles Coombs (1907 - 1980).
Application Insights:
The companion animals segment dominated the market in 2017 and is expected to witness a CAGR of XX% over the forecast period. The growth can be attributed to rising disposable income, which has resulted in an increased number of pet dogs and cats across the globe. According to a study published by American Pet Products Association (APPA), it was estimated that there were 78 million households owning pets in 2016, with an average of 2.5 pets per household globally; however, this number is expected to increase by 10% from 2017 until 2018 owing to increasing consumer spending on pet care products and services.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of animal health testing laboratories, increase in R&D investments by companies and high prevalence of zoonotic diseases. The Asia Pacific is expected to grow at a lucrative CAGR during the forecast period owing to increasing awareness about animal health and rising disposable income levels.
The European region accounted for more than 20% share in 2017 due to increased focus on disease control strategies by various governments across this region. For instance, as per an article published by NCBI; National Cancer Institute (NCI) has developed an online tool that helps clinicians identify patients with cancer who may have been exposed through work or leisure activities or contact with animals between 1970-1979 in Germany and 1980-1989 elsewhere in Europe (1).
Growth Factors:
- Increasing prevalence of autoimmune diseases in animals
- Growing awareness about animal autoimmune diseases and their diagnosis and treatment options
- Rising demand for better and more accurate diagnostic tests for animal autoimmune diseases
- Technological advancements in the field of animal autoimmune disease testing that are making these tests faster, easier to use, and more accurate
- The increasing number of research studies being conducted on animal autoimmune diseases
Scope Of The Report
Report Attributes
Report Details
Report Title
Animal Autoimmune Diseases Testing Market Research Report
By Type
Anti-Nuclear Antibody Testing, Coombs Testing, Lupus Erythematosus Cell Test, Immunofluorescent Antibody Testing, Coagulation Tests, Others
By Application
Companion Animals, Live Stocks Animals
By Companies
Alvedia, VMRD, IVD Technologies, Nova Tec Immundiagnostica, Immunolab
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
130
Number of Tables & Figures
91
Customization Available
Yes, the report can be customized as per your need.
Global Animal Autoimmune Diseases Testing Market Report Segments:
The global Animal Autoimmune Diseases Testing market is segmented on the basis of:
Types
Anti-Nuclear Antibody Testing, Coombs Testing, Lupus Erythematosus Cell Test, Immunofluorescent Antibody Testing, Coagulation Tests, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Companion Animals, Live Stocks Animals
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Alvedia
- VMRD
- IVD Technologies
- Nova Tec Immundiagnostica
- Immunolab
Highlights of The Animal Autoimmune Diseases Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Anti-Nuclear Antibody Testing
- Coombs Testing
- Lupus Erythematosus Cell Test
- Immunofluorescent Antibody Testing
- Coagulation Tests
- Others
- By Application:
- Companion Animals
- Live Stocks Animals
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Animal Autoimmune Diseases Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Animal autoimmune diseases testing is a process that helps identify whether an animal has an autoimmune disease. This type of testing can help veterinarians diagnose and treat animals with autoimmune diseases.
Some of the major companies in the animal autoimmune diseases testing market are Alvedia, VMRD, IVD Technologies, Nova Tec Immundiagnostica, Immunolab.
The animal autoimmune diseases testing market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Animal Autoimmune Diseases Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Animal Autoimmune Diseases Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Animal Autoimmune Diseases Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Animal Autoimmune Diseases Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Animal Autoimmune Diseases Testing Market Size & Forecast, 2018-2028
4.5.1 Animal Autoimmune Diseases Testing Market Size and Y-o-Y Growth
4.5.2 Animal Autoimmune Diseases Testing Market Absolute $ Opportunity
Chapter 5 Global Animal Autoimmune Diseases Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Animal Autoimmune Diseases Testing Market Size Forecast by Type
5.2.1 Anti-Nuclear Antibody Testing
5.2.2 Coombs Testing
5.2.3 Lupus Erythematosus Cell Test
5.2.4 Immunofluorescent Antibody Testing
5.2.5 Coagulation Tests
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Animal Autoimmune Diseases Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Animal Autoimmune Diseases Testing Market Size Forecast by Applications
6.2.1 Companion Animals
6.2.2 Live Stocks Animals
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Animal Autoimmune Diseases Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Animal Autoimmune Diseases Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Animal Autoimmune Diseases Testing Analysis and Forecast
9.1 Introduction
9.2 North America Animal Autoimmune Diseases Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Animal Autoimmune Diseases Testing Market Size Forecast by Type
9.6.1 Anti-Nuclear Antibody Testing
9.6.2 Coombs Testing
9.6.3 Lupus Erythematosus Cell Test
9.6.4 Immunofluorescent Antibody Testing
9.6.5 Coagulation Tests
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Animal Autoimmune Diseases Testing Market Size Forecast by Applications
9.10.1 Companion Animals
9.10.2 Live Stocks Animals
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Animal Autoimmune Diseases Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Animal Autoimmune Diseases Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Animal Autoimmune Diseases Testing Market Size Forecast by Type
10.6.1 Anti-Nuclear Antibody Testing
10.6.2 Coombs Testing
10.6.3 Lupus Erythematosus Cell Test
10.6.4 Immunofluorescent Antibody Testing
10.6.5 Coagulation Tests
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Animal Autoimmune Diseases Testing Market Size Forecast by Applications
10.10.1 Companion Animals
10.10.2 Live Stocks Animals
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Animal Autoimmune Diseases Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Animal Autoimmune Diseases Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Animal Autoimmune Diseases Testing Market Size Forecast by Type
11.6.1 Anti-Nuclear Antibody Testing
11.6.2 Coombs Testing
11.6.3 Lupus Erythematosus Cell Test
11.6.4 Immunofluorescent Antibody Testing
11.6.5 Coagulation Tests
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Animal Autoimmune Diseases Testing Market Size Forecast by Applications
11.10.1 Companion Animals
11.10.2 Live Stocks Animals
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Animal Autoimmune Diseases Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Animal Autoimmune Diseases Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Animal Autoimmune Diseases Testing Market Size Forecast by Type
12.6.1 Anti-Nuclear Antibody Testing
12.6.2 Coombs Testing
12.6.3 Lupus Erythematosus Cell Test
12.6.4 Immunofluorescent Antibody Testing
12.6.5 Coagulation Tests
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Animal Autoimmune Diseases Testing Market Size Forecast by Applications
12.10.1 Companion Animals
12.10.2 Live Stocks Animals
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Animal Autoimmune Diseases Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Animal Autoimmune Diseases Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Animal Autoimmune Diseases Testing Market Size Forecast by Type
13.6.1 Anti-Nuclear Antibody Testing
13.6.2 Coombs Testing
13.6.3 Lupus Erythematosus Cell Test
13.6.4 Immunofluorescent Antibody Testing
13.6.5 Coagulation Tests
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Animal Autoimmune Diseases Testing Market Size Forecast by Applications
13.10.1 Companion Animals
13.10.2 Live Stocks Animals
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Animal Autoimmune Diseases Testing Market: Competitive Dashboard
14.2 Global Animal Autoimmune Diseases Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Alvedia
14.3.2 VMRD
14.3.3 IVD Technologies
14.3.4 Nova Tec Immundiagnostica
14.3.5 Immunolab
